CEACAM6 promotes gastric cancer invasion and metastasis by inducing epithelial-mesenchymal transition via PI3K/AKT signaling pathway - Wikidata - wikimedia - TriplyDB

CEACAM6 promotes gastric cancer invasion and metastasis by inducing epithelial-mesenchymal transition via PI3K/AKT signaling pathway

CEACAM6 promotes gastric cancer invasion and metastasis by inducing epithelial-mesenchymal transition via PI3K/AKT signaling pathway

http://www.wikidata.org/entity/Q34514671

about

Epithelial-mesenchymal transition in gastric cancer Accumulation of low-dose BIX01294 promotes metastatic potential of U251 glioblastoma cells Salvianolic acid A reverses the paclitaxel resistance and inhibits the migration and invasion abilities of human breast cancer cells by inactivating transgelin 2.SHP-2-upregulated ZEB1 is important for PDGFRα-driven glioma epithelial-mesenchymal transition and invasion in mice and humans.Luteolin suppresses gastric cancer progression by reversing epithelial-mesenchymal transition via suppression of the Notch signaling pathway.CEACAM6 is upregulated by Helicobacter pylori CagA and is a biomarker for early gastric cancer.The roles of microRNAs related with progression and metastasis in human cancers.Differential gene expression profiling of matched primary renal cell carcinoma and metastases reveals upregulation of extracellular matrix genes.Dual role of carcinoembryonic antigen-related cell adhesion molecule 6 expression in predicting the overall survival of gastric cancer patients.ING5 knockdown enhances migration and invasion of lung cancer cells by inducing EMT via EGFR/PI3K/Akt and IL-6/STAT3 signaling pathways.PBX3 promotes gastric cancer invasion and metastasis by inducing epithelial-mesenchymal transition.ZHX1 Inhibits Gastric Cancer Cell Growth through Inducing Cell-Cycle Arrest and Apoptosis.CEACAM6 is a prognostic biomarker and potential therapeutic target for gastric carcinoma.Significant associations between driver gene mutations and DNA methylation alterations across many cancer types.The anticipating value of PLK1 for diagnosis, progress and prognosis and its prospective mechanism in gastric cancer: a comprehensive investigation based on high-throughput data and immunohistochemical validation.Downregulation of HADH promotes gastric cancer progression via Akt signaling pathway.Carcinoembryonic antigen-related cell adhesion molecule 6 (CEACAM6) promotes EGF receptor signaling of oral squamous cell carcinoma metastasis via the complex N-glycosylation.BCL6B suppresses proliferation and migration of colorectal carcinoma cells through inhibition of the PI3K/AKT signaling pathway.

P2860

Q26775029-95ED2ADA-A296-45A0-8CC7-1162514CB6BB Q33597842-6685D7DF-7726-419F-988F-8D193776CBEE Q36212778-000E4FFA-B9AF-4734-A470-1283900BDB6E Q37309854-C934B98A-5B2D-41F7-8C75-BFF2F33512DE Q37668355-70B078FE-D63E-4E00-8F49-BCF7C6AE7362 Q37688236-B86CA7EA-2FEE-4722-A611-FDD7587D0695 Q38974714-7DF09571-456C-4F5B-BE08-C174E9E35B15 Q39086320-01427A9E-8083-4EB9-94D3-2CDD2ED37705 Q41534014-C9879C9F-6B09-4758-BB02-54E2A0EC26F5 Q41552636-1BD53BFC-9C49-4511-9D3B-2140D6DC16E0 Q42370617-40AB6C4E-0C94-42E6-8B9E-29DB2C638D24 Q43129471-17711486-35A4-4866-8CD5-FAE8A21093C5 Q46303343-ADE85BA4-D760-4FA5-B230-23A1F225FE64 Q47100621-97C3802A-0C31-4DD3-9171-EE85A1C8C978 Q47143539-4D26BD84-69F4-44E9-A1C1-FF90E5353927 Q47153821-705F2052-B8A3-468B-8366-4049F55444FC Q47823730-C36760D1-32A1-4BB0-9182-AB4E1713A782 Q49379642-ED85B1A7-1CF0-46CF-976C-99B3FCC551EE

P2860

CEACAM6 promotes gastric cancer invasion and metastasis by inducing epithelial-mesenchymal transition via PI3K/AKT signaling pathway

http://www.wikidata.org/entity/Q34514671

description

2014 nî lūn-bûn

@nan

2014 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

CEACAM6 promotes gastric cance ...... via PI3K/AKT signaling pathway

@ast

CEACAM6 promotes gastric cance ...... via PI3K/AKT signaling pathway

@en

CEACAM6 promotes gastric cance ...... via PI3K/AKT signaling pathway

@nl

type

label

CEACAM6 promotes gastric cance ...... via PI3K/AKT signaling pathway

@ast

CEACAM6 promotes gastric cance ...... via PI3K/AKT signaling pathway

@en

CEACAM6 promotes gastric cance ...... via PI3K/AKT signaling pathway

@nl

prefLabel

CEACAM6 promotes gastric cance ...... via PI3K/AKT signaling pathway

@ast

CEACAM6 promotes gastric cance ...... via PI3K/AKT signaling pathway

@en

CEACAM6 promotes gastric cance ...... via PI3K/AKT signaling pathway

@nl

P1433

Q34514671-DD6771B2-43E0-49F9-8FD5-C8EF5C3DB095

P1476

Q34514671-07EFB02E-718D-4332-B3FC-776C9B75F8EC

P2093

Q34514671-003AB60E-BEB0-458B-8153-A98C23CBF846

Q34514671-2597EF8F-E337-42CC-BE5C-9BF776AA051F

Q34514671-516CF42D-12EF-4F03-97DE-381BFA5DBF0E

Q34514671-598F7CDE-B372-43E0-9C22-8E1C9C7B18C1

Q34514671-5A6A6FD2-539B-4207-8201-266220221F7C

Q34514671-683FE896-C27F-4D86-915B-256DDF3F7B34

Q34514671-8C7206B7-76EA-49EB-8815-1FC49795735D

Q34514671-9187EDEE-DCCA-463F-A43D-D757880FBC86

Q34514671-A3A27C06-C4EE-4013-9FA2-A65E311958F6

P2860

Q34514671-01F2203D-AC7B-40FD-AA12-61E794C039A0

Q34514671-030CE488-C8A5-4782-8F25-236996EA5080

Q34514671-0A61EEF9-3514-4084-A828-F70740B0D994

Q34514671-10E13D0E-BBAC-45A2-BC42-331319AD136E

Q34514671-13423536-D614-47B8-A869-F1A48E82B237

Q34514671-1D43ED70-1643-4FA6-9860-05FE532D7279

Q34514671-261B2629-B65D-4406-8512-611D94200236

Q34514671-3164B52B-7EBE-4A81-AD35-04C648F3D99D

Q34514671-37399580-00A5-4BE7-B345-FD4C83938F14

Q34514671-399EF42D-3677-4D66-84D2-573F013FAFD4

P304

Q34514671-2A3EB9AB-1044-4217-A879-8D44D2A3DDB2

P31

Q34514671-5A39D43B-1E5D-423C-BCA7-425636D2AF0A

P356

Q34514671-9A05F781-B9D0-43CB-B1A5-503FA5B944EF

P407

Q34514671-1C8F8FE5-07C7-4544-9834-10EAC6B7F1FB

P433

Q34514671-4838C028-ED4D-49F0-93D8-90118F3081F6

P478

Q34514671-D152F7EB-25B9-43D7-9F3F-0F5D6A4605A8

P577

Q34514671-C164CF48-4CF3-42C5-A451-B90BD20CF6FA

P5875

Q34514671-22BCC933-C12B-4938-8D92-D2655795DFAA

P698

Q34514671-05A5EFB6-D241-4FEF-8EB6-FA3F46073FF8

P932

Q34514671-D8ED7D29-21E9-46F2-9362-BF53F0BFC7D2

P356

JOURNAL.PONE.0112908

P1433

P1476

CEACAM6 promotes gastric cance ...... via PI3K/AKT signaling pathway

@en

P2093

Baogui Zhang

http://www.w3.org/2001/XMLSchema#string

Bingya Liu

http://www.w3.org/2001/XMLSchema#string

Jianfang Li

http://www.w3.org/2001/XMLSchema#string

Liping Su

http://www.w3.org/2001/XMLSchema#string

Min Yan

http://www.w3.org/2001/XMLSchema#string

Mingde Zang

http://www.w3.org/2001/XMLSchema#string

Qinlong Gu

http://www.w3.org/2001/XMLSchema#string

Yunqiang Zhang

http://www.w3.org/2001/XMLSchema#string

Zhenggang Zhu

http://www.w3.org/2001/XMLSchema#string

P2860

Global cancer statistics

The epithelial-mesenchymal transition (EMT) phenomenon

The basics of epithelial-mesenchymal transition

Carcinoembryonic antigen family members CEACAM6 and CEACAM7 are differentially expressed in normal tissues and oppositely deregulated in hyperplastic colorectal polyps and early adenomas

Deregulated expression of the human tumor marker CEA and CEA family member CEACAM6 disrupts tissue architecture and blocks colonocyte differentiation

Epithelial-mesenchymal transitions in development and disease

CEACAM6 gene silencing impairs anoikis resistance and in vivo metastatic ability of pancreatic adenocarcinoma cells

Molecular requirements for epithelial-mesenchymal transition during tumor progression

Downregulation of FAP suppresses cell proliferation and metastasis through PTEN/PI3K/AKT and Ras-ERK signaling in oral squamous cell carcinoma.

Biglycan enhances gastric cancer invasion by activating FAK signaling pathway

P304

e112908

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0112908

http://www.w3.org/2001/XMLSchema#string

P407

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

9

http://www.w3.org/2001/XMLSchema#string

P577

2014-11-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

268281616

http://www.w3.org/2001/XMLSchema#string

P698

25398131

http://www.w3.org/2001/XMLSchema#string

P932

4232574

http://www.w3.org/2001/XMLSchema#string